Kimberly-Clark Offers Concessions to EU for $40B Kenvue Deal Approval

Kimberly-Clark is preparing asset divestitures to address EU antitrust concerns over its $40 billion acquisition of Kenvue, following preliminary review. The concessions aim to secure regulatory approval, though the final outcome remains uncertain. This is a significant M&A development with potential market implications for consumer health sectors.